TR200102692T2 - Kilo artìçì ile iliçkili olan belirli kanserlerin tedavisi - Google Patents

Kilo artìçì ile iliçkili olan belirli kanserlerin tedavisi

Info

Publication number
TR200102692T2
TR200102692T2 TR2001/02692T TR200102692T TR200102692T2 TR 200102692 T2 TR200102692 T2 TR 200102692T2 TR 2001/02692 T TR2001/02692 T TR 2001/02692T TR 200102692 T TR200102692 T TR 200102692T TR 200102692 T2 TR200102692 T2 TR 200102692T2
Authority
TR
Turkey
Prior art keywords
cancer
treatment
weight gain
certain cancers
cancers associated
Prior art date
Application number
TR2001/02692T
Other languages
English (en)
Turkish (tr)
Inventor
M. Mendel Carl
B. Seaton Timothy
P. Weinstein Steve
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of TR200102692T2 publication Critical patent/TR200102692T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2001/02692T 1999-03-19 2000-03-17 Kilo artìçì ile iliçkili olan belirli kanserlerin tedavisi TR200102692T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12525099P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
TR200102692T2 true TR200102692T2 (tr) 2002-03-21

Family

ID=22418838

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02692T TR200102692T2 (tr) 1999-03-19 2000-03-17 Kilo artìçì ile iliçkili olan belirli kanserlerin tedavisi

Country Status (19)

Country Link
EP (1) EP1171106A1 (ja)
JP (1) JP2002539255A (ja)
KR (1) KR20010113765A (ja)
CN (1) CN1399545A (ja)
AU (1) AU3632000A (ja)
BG (1) BG105998A (ja)
BR (1) BR0009161A (ja)
CA (1) CA2367045A1 (ja)
CZ (1) CZ20013281A3 (ja)
HU (1) HUP0200497A2 (ja)
IL (1) IL145239A0 (ja)
MX (1) MXPA01009470A (ja)
NO (1) NO20014478L (ja)
NZ (1) NZ514012A (ja)
PL (1) PL351958A1 (ja)
SK (1) SK13372001A3 (ja)
TR (1) TR200102692T2 (ja)
WO (1) WO2000056323A1 (ja)
ZA (1) ZA200107687B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096202A1 (en) * 2003-04-28 2004-11-11 Cipla Limited Pharmaceutical formulation comprising anti-obesity agent and acidulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
CZ20013281A3 (cs) 2002-07-17
BR0009161A (pt) 2002-01-22
CN1399545A (zh) 2003-02-26
AU3632000A (en) 2000-10-09
KR20010113765A (ko) 2001-12-28
SK13372001A3 (sk) 2002-07-02
EP1171106A1 (en) 2002-01-16
IL145239A0 (en) 2002-06-30
HUP0200497A2 (en) 2002-08-28
NO20014478L (no) 2001-10-29
WO2000056323A1 (en) 2000-09-28
CA2367045A1 (en) 2000-09-28
JP2002539255A (ja) 2002-11-19
MXPA01009470A (es) 2004-03-19
NZ514012A (en) 2001-09-28
BG105998A (en) 2002-06-28
ZA200107687B (en) 2002-12-18
NO20014478D0 (no) 2001-09-14
PL351958A1 (en) 2003-07-14

Similar Documents

Publication Publication Date Title
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
CY1116145T1 (el) S-φθορομεθυλεστερας 6.αλφα.,9.αλφα-διφθορο-17.αλφα.-'(2-φουρανυλκαρβοξυλ) οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4-διεν-17-καρβοθειοτικου οξεος ως αντιφλεγμονωδης παραγοντας
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
CY1112178T1 (el) Παραγωγα πιπεραζινης και χρηση αυτων ως θεραπευτικων παραγοντων
TNSN06033A1 (en) Piperazine derivatives and their use as therapeutic agents
JO2248B1 (en) Pirazolobenzodiazepines
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
DK1157037T3 (da) GCSF-konjugater
TR200102800T2 (tr) Yeni bileşikler.
TNSN03110A1 (en) Azaindoles.
CY1112086T1 (el) Συνδυασμος γλυκοπυρρολικου αλατος και ενος αγωνιστη βητα2 αδρενεργικων υποδοχεων
CY1107815T1 (el) 1,3 - διϋποκατεστημεναι και 1,3,3 -τριϋποκατεστημεναι πυρρολιδιναι ως συνδεσμικα μεσα υποδοχεως ισταμινης -3, και θεραπευτικαι εφαρμογαι των
TR200200795T2 (tr) 5-HT1B antagonistleri olarak piperazin türevleri
SE9900961D0 (sv) Novel compounds
TR200103460T2 (tr) 5-Fenil-pirimidin türevleri
SE0004245D0 (sv) Novel compounds and their use
MXPA03002911A (es) Compuestos quimicos.
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
ATE345349T1 (de) Purinderivate
DK1379508T3 (da) N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
TR200102692T2 (tr) Kilo artìçì ile iliçkili olan belirli kanserlerin tedavisi
TR200102695T2 (tr) Tedavi edici ilaçlarla ilişkili olarak kilo alımının kontrol edilmesi
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate